The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Human Induced Pluripotent Stem Cells (iPSCs) Market Research Report 2025
Synopsis
Induced pluripotent stem cells (iPSCs) are genetically reprogrammed adult cells that exhibit a pluripotent stem cell-like state similar to embryonic stem cells.1 While these artificially generated cells are not known to exist in the human body, they show qualities remarkably similar to those of embryonic stem cells (ESCs); thus, iPSCs are an invaluable resource for drug discovery, cell therapy, and basic research.
The global Human Induced Pluripotent Stem Cells (iPSCs) market was valued at US$ 115 million in 2023 and is anticipated to reach US$ 365.4 million by 2030, witnessing a CAGR of 18.2% during the forecast period 2024-2030.
North American market for Human Induced Pluripotent Stem Cells (iPSCs) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Human Induced Pluripotent Stem Cells (iPSCs) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Human Induced Pluripotent Stem Cells (iPSCs) in Academic Research is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Human Induced Pluripotent Stem Cells (iPSCs) include FUJIFILM Cellular Dynamics, Takara Bio, Thermo Fisher Scientific, Ncardia, Sumitomo Dainippon Pharma, Astellas Pharma, Fate Therapeutics, Cell Inspire Biotechnology and ReproCELL, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Human Induced Pluripotent Stem Cells (iPSCs), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Induced Pluripotent Stem Cells (iPSCs).
Report Scope
The Human Induced Pluripotent Stem Cells (iPSCs) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Induced Pluripotent Stem Cells (iPSCs) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Induced Pluripotent Stem Cells (iPSCs) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
FUJIFILM Cellular Dynamics
Takara Bio
Thermo Fisher Scientific
Ncardia
Sumitomo Dainippon Pharma
Astellas Pharma
Fate Therapeutics
Cell Inspire Biotechnology
ReproCELL
AcceGen
Segment by Type
Skin
Blood
Others
Segment by Application
Academic Research
Drug Development and Discovery
Toxicity Screening
Regenerative Medicine
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Induced Pluripotent Stem Cells (iPSCs) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Induced pluripotent stem cells (iPSCs) are genetically reprogrammed adult cells that exhibit a pluripotent stem cell-like state similar to embryonic stem cells.1 While these artificially generated cells are not known to exist in the human body, they show qualities remarkably similar to those of embryonic stem cells (ESCs); thus, iPSCs are an invaluable resource for drug discovery, cell therapy, and basic research.
The global Human Induced Pluripotent Stem Cells (iPSCs) market was valued at US$ 115 million in 2023 and is anticipated to reach US$ 365.4 million by 2030, witnessing a CAGR of 18.2% during the forecast period 2024-2030.
North American market for Human Induced Pluripotent Stem Cells (iPSCs) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Human Induced Pluripotent Stem Cells (iPSCs) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Human Induced Pluripotent Stem Cells (iPSCs) in Academic Research is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Human Induced Pluripotent Stem Cells (iPSCs) include FUJIFILM Cellular Dynamics, Takara Bio, Thermo Fisher Scientific, Ncardia, Sumitomo Dainippon Pharma, Astellas Pharma, Fate Therapeutics, Cell Inspire Biotechnology and ReproCELL, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Human Induced Pluripotent Stem Cells (iPSCs), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Induced Pluripotent Stem Cells (iPSCs).
Report Scope
The Human Induced Pluripotent Stem Cells (iPSCs) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Induced Pluripotent Stem Cells (iPSCs) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Induced Pluripotent Stem Cells (iPSCs) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
FUJIFILM Cellular Dynamics
Takara Bio
Thermo Fisher Scientific
Ncardia
Sumitomo Dainippon Pharma
Astellas Pharma
Fate Therapeutics
Cell Inspire Biotechnology
ReproCELL
AcceGen
Segment by Type
Skin
Blood
Others
Segment by Application
Academic Research
Drug Development and Discovery
Toxicity Screening
Regenerative Medicine
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Induced Pluripotent Stem Cells (iPSCs) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Skin
1.2.3 Blood
1.2.4 Others
1.3 Market by Application
1.3.1 Global Human Induced Pluripotent Stem Cells (iPSCs) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Academic Research
1.3.3 Drug Development and Discovery
1.3.4 Toxicity Screening
1.3.5 Regenerative Medicine
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Human Induced Pluripotent Stem Cells (iPSCs) Market Perspective (2019-2030)
2.2 Human Induced Pluripotent Stem Cells (iPSCs) Growth Trends by Region
2.2.1 Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Human Induced Pluripotent Stem Cells (iPSCs) Historic Market Size by Region (2019-2024)
2.2.3 Human Induced Pluripotent Stem Cells (iPSCs) Forecasted Market Size by Region (2025-2030)
2.3 Human Induced Pluripotent Stem Cells (iPSCs) Market Dynamics
2.3.1 Human Induced Pluripotent Stem Cells (iPSCs) Industry Trends
2.3.2 Human Induced Pluripotent Stem Cells (iPSCs) Market Drivers
2.3.3 Human Induced Pluripotent Stem Cells (iPSCs) Market Challenges
2.3.4 Human Induced Pluripotent Stem Cells (iPSCs) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Human Induced Pluripotent Stem Cells (iPSCs) Players by Revenue
3.1.1 Global Top Human Induced Pluripotent Stem Cells (iPSCs) Players by Revenue (2019-2024)
3.1.2 Global Human Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Players (2019-2024)
3.2 Global Human Induced Pluripotent Stem Cells (iPSCs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Human Induced Pluripotent Stem Cells (iPSCs) Revenue
3.4 Global Human Induced Pluripotent Stem Cells (iPSCs) Market Concentration Ratio
3.4.1 Global Human Induced Pluripotent Stem Cells (iPSCs) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Induced Pluripotent Stem Cells (iPSCs) Revenue in 2023
3.5 Human Induced Pluripotent Stem Cells (iPSCs) Key Players Head office and Area Served
3.6 Key Players Human Induced Pluripotent Stem Cells (iPSCs) Product Solution and Service
3.7 Date of Enter into Human Induced Pluripotent Stem Cells (iPSCs) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Human Induced Pluripotent Stem Cells (iPSCs) Breakdown Data by Type
4.1 Global Human Induced Pluripotent Stem Cells (iPSCs) Historic Market Size by Type (2019-2024)
4.2 Global Human Induced Pluripotent Stem Cells (iPSCs) Forecasted Market Size by Type (2025-2030)
5 Human Induced Pluripotent Stem Cells (iPSCs) Breakdown Data by Application
5.1 Global Human Induced Pluripotent Stem Cells (iPSCs) Historic Market Size by Application (2019-2024)
5.2 Global Human Induced Pluripotent Stem Cells (iPSCs) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Human Induced Pluripotent Stem Cells (iPSCs) Market Size (2019-2030)
6.2 North America Human Induced Pluripotent Stem Cells (iPSCs) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2019-2024)
6.4 North America Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Human Induced Pluripotent Stem Cells (iPSCs) Market Size (2019-2030)
7.2 Europe Human Induced Pluripotent Stem Cells (iPSCs) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2019-2024)
7.4 Europe Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Human Induced Pluripotent Stem Cells (iPSCs) Market Size (2019-2030)
8.2 Asia-Pacific Human Induced Pluripotent Stem Cells (iPSCs) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2019-2024)
8.4 Asia-Pacific Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Human Induced Pluripotent Stem Cells (iPSCs) Market Size (2019-2030)
9.2 Latin America Human Induced Pluripotent Stem Cells (iPSCs) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2019-2024)
9.4 Latin America Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Human Induced Pluripotent Stem Cells (iPSCs) Market Size (2019-2030)
10.2 Middle East & Africa Human Induced Pluripotent Stem Cells (iPSCs) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2019-2024)
10.4 Middle East & Africa Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 FUJIFILM Cellular Dynamics
11.1.1 FUJIFILM Cellular Dynamics Company Detail
11.1.2 FUJIFILM Cellular Dynamics Business Overview
11.1.3 FUJIFILM Cellular Dynamics Human Induced Pluripotent Stem Cells (iPSCs) Introduction
11.1.4 FUJIFILM Cellular Dynamics Revenue in Human Induced Pluripotent Stem Cells (iPSCs) Business (2019-2024)
11.1.5 FUJIFILM Cellular Dynamics Recent Development
11.2 Takara Bio
11.2.1 Takara Bio Company Detail
11.2.2 Takara Bio Business Overview
11.2.3 Takara Bio Human Induced Pluripotent Stem Cells (iPSCs) Introduction
11.2.4 Takara Bio Revenue in Human Induced Pluripotent Stem Cells (iPSCs) Business (2019-2024)
11.2.5 Takara Bio Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Detail
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Human Induced Pluripotent Stem Cells (iPSCs) Introduction
11.3.4 Thermo Fisher Scientific Revenue in Human Induced Pluripotent Stem Cells (iPSCs) Business (2019-2024)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 Ncardia
11.4.1 Ncardia Company Detail
11.4.2 Ncardia Business Overview
11.4.3 Ncardia Human Induced Pluripotent Stem Cells (iPSCs) Introduction
11.4.4 Ncardia Revenue in Human Induced Pluripotent Stem Cells (iPSCs) Business (2019-2024)
11.4.5 Ncardia Recent Development
11.5 Sumitomo Dainippon Pharma
11.5.1 Sumitomo Dainippon Pharma Company Detail
11.5.2 Sumitomo Dainippon Pharma Business Overview
11.5.3 Sumitomo Dainippon Pharma Human Induced Pluripotent Stem Cells (iPSCs) Introduction
11.5.4 Sumitomo Dainippon Pharma Revenue in Human Induced Pluripotent Stem Cells (iPSCs) Business (2019-2024)
11.5.5 Sumitomo Dainippon Pharma Recent Development
11.6 Astellas Pharma
11.6.1 Astellas Pharma Company Detail
11.6.2 Astellas Pharma Business Overview
11.6.3 Astellas Pharma Human Induced Pluripotent Stem Cells (iPSCs) Introduction
11.6.4 Astellas Pharma Revenue in Human Induced Pluripotent Stem Cells (iPSCs) Business (2019-2024)
11.6.5 Astellas Pharma Recent Development
11.7 Fate Therapeutics
11.7.1 Fate Therapeutics Company Detail
11.7.2 Fate Therapeutics Business Overview
11.7.3 Fate Therapeutics Human Induced Pluripotent Stem Cells (iPSCs) Introduction
11.7.4 Fate Therapeutics Revenue in Human Induced Pluripotent Stem Cells (iPSCs) Business (2019-2024)
11.7.5 Fate Therapeutics Recent Development
11.8 Cell Inspire Biotechnology
11.8.1 Cell Inspire Biotechnology Company Detail
11.8.2 Cell Inspire Biotechnology Business Overview
11.8.3 Cell Inspire Biotechnology Human Induced Pluripotent Stem Cells (iPSCs) Introduction
11.8.4 Cell Inspire Biotechnology Revenue in Human Induced Pluripotent Stem Cells (iPSCs) Business (2019-2024)
11.8.5 Cell Inspire Biotechnology Recent Development
11.9 ReproCELL
11.9.1 ReproCELL Company Detail
11.9.2 ReproCELL Business Overview
11.9.3 ReproCELL Human Induced Pluripotent Stem Cells (iPSCs) Introduction
11.9.4 ReproCELL Revenue in Human Induced Pluripotent Stem Cells (iPSCs) Business (2019-2024)
11.9.5 ReproCELL Recent Development
11.10 AcceGen
11.10.1 AcceGen Company Detail
11.10.2 AcceGen Business Overview
11.10.3 AcceGen Human Induced Pluripotent Stem Cells (iPSCs) Introduction
11.10.4 AcceGen Revenue in Human Induced Pluripotent Stem Cells (iPSCs) Business (2019-2024)
11.10.5 AcceGen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Skin
Table 3. Key Players of Blood
Table 4. Key Players of Others
Table 5. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Share by Region (2019-2024)
Table 9. Global Human Induced Pluripotent Stem Cells (iPSCs) Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Share by Region (2025-2030)
Table 11. Human Induced Pluripotent Stem Cells (iPSCs) Market Trends
Table 12. Human Induced Pluripotent Stem Cells (iPSCs) Market Drivers
Table 13. Human Induced Pluripotent Stem Cells (iPSCs) Market Challenges
Table 14. Human Induced Pluripotent Stem Cells (iPSCs) Market Restraints
Table 15. Global Human Induced Pluripotent Stem Cells (iPSCs) Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Share by Players (2019-2024)
Table 17. Global Top Human Induced Pluripotent Stem Cells (iPSCs) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Induced Pluripotent Stem Cells (iPSCs) as of 2023)
Table 18. Ranking of Global Top Human Induced Pluripotent Stem Cells (iPSCs) Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Human Induced Pluripotent Stem Cells (iPSCs) Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Human Induced Pluripotent Stem Cells (iPSCs) Product Solution and Service
Table 22. Date of Enter into Human Induced Pluripotent Stem Cells (iPSCs) Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Human Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Type (2019-2024)
Table 26. Global Human Induced Pluripotent Stem Cells (iPSCs) Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Human Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Type (2025-2030)
Table 28. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Human Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Application (2019-2024)
Table 30. Global Human Induced Pluripotent Stem Cells (iPSCs) Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Human Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Application (2025-2030)
Table 32. North America Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2025-2030) & (US$ Million)
Table 47. FUJIFILM Cellular Dynamics Company Detail
Table 48. FUJIFILM Cellular Dynamics Business Overview
Table 49. FUJIFILM Cellular Dynamics Human Induced Pluripotent Stem Cells (iPSCs) Product
Table 50. FUJIFILM Cellular Dynamics Revenue in Human Induced Pluripotent Stem Cells (iPSCs) Business (2019-2024) & (US$ Million)
Table 51. FUJIFILM Cellular Dynamics Recent Development
Table 52. Takara Bio Company Detail
Table 53. Takara Bio Business Overview
Table 54. Takara Bio Human Induced Pluripotent Stem Cells (iPSCs) Product
Table 55. Takara Bio Revenue in Human Induced Pluripotent Stem Cells (iPSCs) Business (2019-2024) & (US$ Million)
Table 56. Takara Bio Recent Development
Table 57. Thermo Fisher Scientific Company Detail
Table 58. Thermo Fisher Scientific Business Overview
Table 59. Thermo Fisher Scientific Human Induced Pluripotent Stem Cells (iPSCs) Product
Table 60. Thermo Fisher Scientific Revenue in Human Induced Pluripotent Stem Cells (iPSCs) Business (2019-2024) & (US$ Million)
Table 61. Thermo Fisher Scientific Recent Development
Table 62. Ncardia Company Detail
Table 63. Ncardia Business Overview
Table 64. Ncardia Human Induced Pluripotent Stem Cells (iPSCs) Product
Table 65. Ncardia Revenue in Human Induced Pluripotent Stem Cells (iPSCs) Business (2019-2024) & (US$ Million)
Table 66. Ncardia Recent Development
Table 67. Sumitomo Dainippon Pharma Company Detail
Table 68. Sumitomo Dainippon Pharma Business Overview
Table 69. Sumitomo Dainippon Pharma Human Induced Pluripotent Stem Cells (iPSCs) Product
Table 70. Sumitomo Dainippon Pharma Revenue in Human Induced Pluripotent Stem Cells (iPSCs) Business (2019-2024) & (US$ Million)
Table 71. Sumitomo Dainippon Pharma Recent Development
Table 72. Astellas Pharma Company Detail
Table 73. Astellas Pharma Business Overview
Table 74. Astellas Pharma Human Induced Pluripotent Stem Cells (iPSCs) Product
Table 75. Astellas Pharma Revenue in Human Induced Pluripotent Stem Cells (iPSCs) Business (2019-2024) & (US$ Million)
Table 76. Astellas Pharma Recent Development
Table 77. Fate Therapeutics Company Detail
Table 78. Fate Therapeutics Business Overview
Table 79. Fate Therapeutics Human Induced Pluripotent Stem Cells (iPSCs) Product
Table 80. Fate Therapeutics Revenue in Human Induced Pluripotent Stem Cells (iPSCs) Business (2019-2024) & (US$ Million)
Table 81. Fate Therapeutics Recent Development
Table 82. Cell Inspire Biotechnology Company Detail
Table 83. Cell Inspire Biotechnology Business Overview
Table 84. Cell Inspire Biotechnology Human Induced Pluripotent Stem Cells (iPSCs) Product
Table 85. Cell Inspire Biotechnology Revenue in Human Induced Pluripotent Stem Cells (iPSCs) Business (2019-2024) & (US$ Million)
Table 86. Cell Inspire Biotechnology Recent Development
Table 87. ReproCELL Company Detail
Table 88. ReproCELL Business Overview
Table 89. ReproCELL Human Induced Pluripotent Stem Cells (iPSCs) Product
Table 90. ReproCELL Revenue in Human Induced Pluripotent Stem Cells (iPSCs) Business (2019-2024) & (US$ Million)
Table 91. ReproCELL Recent Development
Table 92. AcceGen Company Detail
Table 93. AcceGen Business Overview
Table 94. AcceGen Human Induced Pluripotent Stem Cells (iPSCs) Product
Table 95. AcceGen Revenue in Human Induced Pluripotent Stem Cells (iPSCs) Business (2019-2024) & (US$ Million)
Table 96. AcceGen Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Share by Type: 2023 VS 2030
Figure 3. Skin Features
Figure 4. Blood Features
Figure 5. Others Features
Figure 6. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Share by Application: 2023 VS 2030
Figure 8. Academic Research Case Studies
Figure 9. Drug Development and Discovery Case Studies
Figure 10. Toxicity Screening Case Studies
Figure 11. Regenerative Medicine Case Studies
Figure 12. Others Case Studies
Figure 13. Human Induced Pluripotent Stem Cells (iPSCs) Report Years Considered
Figure 14. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Share by Region: 2023 VS 2030
Figure 17. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Share by Players in 2023
Figure 18. Global Top Human Induced Pluripotent Stem Cells (iPSCs) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Induced Pluripotent Stem Cells (iPSCs) as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Human Induced Pluripotent Stem Cells (iPSCs) Revenue in 2023
Figure 20. North America Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Human Induced Pluripotent Stem Cells (iPSCs) Market Share by Country (2019-2030)
Figure 22. United States Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Human Induced Pluripotent Stem Cells (iPSCs) Market Share by Country (2019-2030)
Figure 26. Germany Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Human Induced Pluripotent Stem Cells (iPSCs) Market Share by Region (2019-2030)
Figure 34. China Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Human Induced Pluripotent Stem Cells (iPSCs) Market Share by Country (2019-2030)
Figure 42. Mexico Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Human Induced Pluripotent Stem Cells (iPSCs) Market Share by Country (2019-2030)
Figure 46. Turkey Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Human Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. FUJIFILM Cellular Dynamics Revenue Growth Rate in Human Induced Pluripotent Stem Cells (iPSCs) Business (2019-2024)
Figure 49. Takara Bio Revenue Growth Rate in Human Induced Pluripotent Stem Cells (iPSCs) Business (2019-2024)
Figure 50. Thermo Fisher Scientific Revenue Growth Rate in Human Induced Pluripotent Stem Cells (iPSCs) Business (2019-2024)
Figure 51. Ncardia Revenue Growth Rate in Human Induced Pluripotent Stem Cells (iPSCs) Business (2019-2024)
Figure 52. Sumitomo Dainippon Pharma Revenue Growth Rate in Human Induced Pluripotent Stem Cells (iPSCs) Business (2019-2024)
Figure 53. Astellas Pharma Revenue Growth Rate in Human Induced Pluripotent Stem Cells (iPSCs) Business (2019-2024)
Figure 54. Fate Therapeutics Revenue Growth Rate in Human Induced Pluripotent Stem Cells (iPSCs) Business (2019-2024)
Figure 55. Cell Inspire Biotechnology Revenue Growth Rate in Human Induced Pluripotent Stem Cells (iPSCs) Business (2019-2024)
Figure 56. ReproCELL Revenue Growth Rate in Human Induced Pluripotent Stem Cells (iPSCs) Business (2019-2024)
Figure 57. AcceGen Revenue Growth Rate in Human Induced Pluripotent Stem Cells (iPSCs) Business (2019-2024)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
